BIOMAT Database Logo BIOMAT Database Logo

Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography. 1996

T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
Pneumology Department, CHU Sart Tilman, B-4000 Liege, Belgium.

Positron emission tomography (PET) using fluorine-18 deoxyglucose (FDG), showing increased FDG uptake and retention in malignant cells, has been proven useful to differentiate malignant from benign tissue. We undertook a prospective study in 61 patients to compare the accuracy of whole-body FDG PET and conventional imaging (CI) methods for the staging of non-small-cell lung cancer (NSCLC). CI included chest and abdomen computed tomographic scanning and bone scintigraphy. When CI or PET study suggested metastatic disease, confirmation was obtained by biopsy or clinical or radiological follow-up. As compared to CI, PET correctly changed the N stage in 13 patients (21%) and the M stage in six patients (10%). There were three false-positive and no false-negative distant PET findings. Our preliminary results show that whole-body FDG PET can improve the diagnostic accuracy in the staging of NSCLC.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D005260 Female Females
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine

Related Publications

T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer.
January 2002, Anticancer research,
T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer.
January 2001, Oncology reports,
T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
Staging non-small cell lung cancer by whole-body positron emission tomographic imaging.
December 1995, The Annals of thoracic surgery,
T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.
March 1999, The Annals of thoracic surgery,
T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.
September 1998, European journal of nuclear medicine,
T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.
June 1993, Cancer,
T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer.
July 2003, The Journal of urology,
T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer.
January 2002, Clinical nephrology,
T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
Staging of non-small-cell lung cancer with positron-emission tomography.
November 2000, The New England journal of medicine,
T Bury, and A Dowlati, and P Paulus, and R Hustinx, and M Radermecker, and P Rigo
Staging of non-small-cell lung cancer with positron-emission tomography.
November 2000, The New England journal of medicine,
Copied contents to your clipboard!